PR Newswire | Feb 16, 2021 07:02AM EST

02/16 06:00 CST

Bausch Health Announces Participation In Upcoming Investor Conferences LAVAL, QC, Feb. 16, 2021

LAVAL, QC, Feb. 16, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC, TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in three upcoming investor conferences.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, senior vice president and corporate controller; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Cowen & Co. 41st Annual Health Care Conference on March 1, 2021 at 11:00 a.m. ET.

Paul S. Herendeen, executive vice president and chief financial officer; Sam Eldessouky, senior vice president and corporate controller; William Woodfield, vice president and treasurer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the J.P. Morgan Global High Yield & Leveraged Finance Conference in on March 3, 2021 at 8:30 a.m. ET.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, senior vice president and corporate controller; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Barclays Global Healthcare Conference 2021 on March 9, 2021 at 2:25 p.m. ET.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2021.

About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact: Media Contact:

Arthur Shannon Lainie Keller

arthur.shannon@bauschhealth.com lainie.keller@bauschhealth.com

(514) 856-3855 (908) 927-1198

(877) 281-6642 (toll free)

View original content to download multimedia: http://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301228591.html

SOURCE Bausch Health Companies Inc.